Use of the Quantra QPlus Sytem in Cardiac Surgery
Utilization of the Quantra QPlus System to Guide the Management of Blood Product Transfusions in Cardiac Surgery Patients: Effects on Clinical and Economic Outcomes
1 other identifier
observational
128
1 country
1
Brief Summary
Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedFirst Submitted
Initial submission to the registry
July 26, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedAugust 15, 2022
August 1, 2022
5 months
July 26, 2022
August 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Blood product utilization
Units of blood products administered to patient
Intraoperative - during surgery
Blood product utilization
Units of blood products administered to patient
Postoperative - after surgery throughout the rest of the hospital stay, assessed up to 30 days
Cost of blood products
Total cost of blood products administered to patient
Throughout the entire hospital stay, assessed up to 30 days
Study Arms (2)
Pre-Quantra
Patients undergoing cardiac surgery prior to the introduction of the Quantra.
Post-Quantra
Patients undergoing cardiac surgery after the introduction of the Quantra.
Interventions
Eligibility Criteria
Patients undergoing cardiac surgery performed by the same surgical team.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- HemoSonics LLClead
Study Sites (1)
Yavapai Regional Medical Center
Prescott, Arizona, 86301, United States
Related Publications (1)
Tibi P, Thompson J, Attaran S, Black E. Retrospective study assessing outcomes in cardiac surgery after implementation of Quantra. J Cardiothorac Surg. 2023 Apr 17;18(1):149. doi: 10.1186/s13019-023-02245-x.
PMID: 37069685DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Tibi, MD
Yavapai Regional Medical Center
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2022
First Posted
August 15, 2022
Study Start
June 15, 2021
Primary Completion
November 21, 2021
Study Completion
December 15, 2021
Last Updated
August 15, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share